General Information of Drug Transporter (DT)
DT ID DTD0295 Transporter Info
Gene Name SLC35B4
Transporter Name UDP-xylose and UDP-N-acetylglucosamine transporter
Gene ID
84912
UniProt ID
Q969S0
Post-Translational Modification of This DT
Overview of SLC35B4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X: Amino Acid

Phosphorylation

  Serine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35B4 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

117

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B4 Serine 117 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35B4 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

192

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B4 Serine 192 has the potential to affect its expression or activity.

  Threonine

          4 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35B4 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

183

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B4 Threonine 183 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35B4 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

262

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B4 Threonine 262 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC35B4 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

268

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B4 Threonine 268 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC35B4 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

274

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35B4 Threonine 274 has the potential to affect its expression or activity.
References
1 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
2 Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
3 iTRAQ labeling is superior to mTRAQ for quantitative global proteomics and phosphoproteomics. Mol Cell Proteomics. 2012 Jun;11(6):M111.014423.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.